Net profit of Sun Pharmaceutical Industries declined 19.01% to Rs 2149.88 crore in the quarter ended March 2025 as against Rs 2654.58 crore during the previous quarter ended March 2024. Sales rose 8.48% to Rs 12815.58 crore in the quarter ended March 2025 as against Rs 11813.33 crore during the previous quarter ended March 2024.
For the full year,net profit rose 14.12% to Rs 10929.04 crore in the year ended March 2025 as against Rs 9576.38 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 52041.25 crore in the year ended March 2025 as against Rs 47758.45 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 12815.58 | 11813.33 | 8 | 52041.25 | 47758.45 | 9 |
| OPM % | 29.00 | 25.69 | - | 29.35 | 27.27 | - |
| PBDT | 4279.82 | 3567.52 | 20 | 17005.37 | 14138.85 | 20 |
| PBT | 3616.03 | 2917.16 | 24 | 14429.98 | 11582.21 | 25 |
| NP | 2149.88 | 2654.58 | -19 | 10929.04 | 9576.38 | 14 |